| Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? S Mirzaei, A Zarrabi, F Hashemi, A Zabolian, H Saleki, A Ranjbar, ... Cancer Letters 509, 63-80, 2021 | 184 | 2021 |
| Islanding detection for inverter-based DG coupled with using an adaptive neuro-fuzzy inference system F Hashemi, N Ghadimi, B Sobhani International Journal of Electrical Power & Energy Systems 45 (1), 443-455, 2013 | 135 | 2013 |
| New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities M Ashrafizadeh, S Mirzaei, F Hashemi, A Zarrabi, A Zabolian, H Saleki, ... Biomedicine & Pharmacotherapy 141, 111824, 2021 | 130 | 2021 |
| Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects M Ashrafizadeh, A Zarrabi, F Hashemi, ER Moghadam, F Hashemi, ... Life sciences 256, 117984, 2020 | 122 | 2020 |
| Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression M Ashrafizadeh, S Mirzaei, MH Gholami, F Hashemi, A Zabolian, M Raei, ... Carbohydrate polymers 272, 118491, 2021 | 120 | 2021 |
| Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy M Ashrafizadeh, M Delfi, F Hashemi, A Zabolian, H Saleki, M Bagherian, ... Carbohydrate Polymers 260, 117809, 2021 | 116 | 2021 |
| Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects AJ Abadi, S Mirzaei, MK Mahabady, F Hashemi, A Zabolian, F Hashemi, ... Phytotherapy Research 36 (1), 189-213, 2022 | 113 | 2022 |
| Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects S Mirzaei, MH Gholami, F Hashemi, A Zabolian, MV Farahani, ... Drug Discovery Today 27 (2), 436-455, 2022 | 106 | 2022 |
| Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance S Mirzaei, AT Mohammadi, MH Gholami, F Hashemi, A Zarrabi, ... Pharmacological research 167, 105575, 2021 | 105 | 2021 |
| The long and short non-coding RNAs modulating EZH2 signaling in cancer S Mirzaei, MH Gholami, K Hushmandi, F Hashemi, A Zabolian, I Canadas, ... Journal of hematology & oncology 15 (1), 18, 2022 | 102 | 2022 |
| Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi, ER Moghadam, ... Cellular signalling 78, 109871, 2021 | 100 | 2021 |
| Minimum non detection zone for islanding detection using an optimal Artificial Neural Network algorithm based on PSO H Samet, F Hashemi, T Ghanbari Renewable and Sustainable Energy Reviews 52, 1-18, 2015 | 89 | 2015 |
| Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response M Ashrafizadeh, MDA Paskeh, S Mirzaei, MH Gholami, A Zarrabi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 105, 2022 | 85 | 2022 |
| Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: enhancing antitumor activity M Ashrafizadeh, A Zarrabi, F Hashemi, A Zabolian, H Saleki, M Bagherian, ... Pharmaceutics 12 (11), 1084, 2020 | 83 | 2020 |
| Islanding detection method for microgrid based on extracted features from differential transient rate of change of frequency F Hashemi, M Mohammadi, A Kargarian IET Generation, Transmission & Distribution 11 (4), 891-904, 2017 | 80 | 2017 |
| Islanding detection method for inverter-based distributed generation with negligible non-detection zone using energy of rate of change of voltage phase angle H Samet, F Hashemi, T Ghanbari IET Generation, Transmission & Distribution 9 (15), 2337-2350, 2015 | 79 | 2015 |
| Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery S Mirzaei, A Zarrabi, F Hashemi, A Zabolian, H Saleki, N Azami, ... Antioxidants 10 (3), 349, 2021 | 77 | 2021 |
| Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy S Mirzaei, MH Gholami, F Hashemi, A Zabolian, K Hushmandi, ... Life Sciences 277, 119430, 2021 | 72 | 2021 |
| Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems S Mirzaei, MK Mahabady, A Zabolian, A Abbaspour, P Fallahzadeh, ... Life Sciences 275, 119368, 2021 | 71 | 2021 |
| Progress in natural compounds/siRNA co-delivery employing nanovehicles for cancer therapy M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi, ... ACS combinatorial science 22 (12), 669-700, 2020 | 70 | 2020 |
Haidar SametProfessor, Shiraz UniversityVerified email at shirazu.ac.ir
